About
Eric has been a distinguished medicinal chemist, company founder and senior executive since the early 1970s. He was head of medicinal chemistry at Squibb and Bristol Myers Squibb in Princeton, where he worked for 18 years. In 1992, he became Vice President of Research and Director of Chemistry at Affymax in Palo Alto, and had that role until the company was sold to Glaxo in 1995. In 1996, he became scientific co-founder, President and Chief Scientific Officer of Versicor (later Vicuron Pharmaceuticals, which was acquired by Pfizer in 2005). In 1998 he participated in the early stages of Sunesis Pharmaceuticals (NASDAQ: SNSS) and was Senior Vice President of Research until late 2002. He is an accepted authority on combinatorial chemistry, medicinal chemistry, and creating drugs through enzyme inhibition. Eric has authored more than 200 scientific manuscripts and U.S. patents, and portions of 3 books, including editing a comprehensive book on combinatorial chemistry. He is the seni
Position in the VCSift Database
- • 4 investors at Skyline Ventures are tracked.
- • 46 investors hold the Founder & Partner role in VCSift. Eric M Gordon is one of them.
- • 931 investors are based in Palo Alto, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Palo Alto, US
Contact Information
Find more investors like Eric
Search Investors